Relationship between HLA-DP gene polymorphisms and clearance of chronic hepatitis B virus infections: Case-control study and meta-analysis

Infection, Genetics and Evolution

Volumn 12, Issue 6, 2012, Pages 1222-1228

  Yan, Zehui ^a   Tan, Shun ^a   Dan, Yunjie ^a   Sun, Xiaowen ^a   Deng, Guohong ^a   Wang, Yuming ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

CHB; HBV; Hepatitis B virus (HBV); HLA; Human leukocyte antigens DP (HLA DP); Meta analysis; Polymorphism; SNP

Indexed keywords

HLA DP ANTIGEN; VIRUS DNA;

ADULT; AGE; ALCOHOL CONSUMPTION; ALLELE; ARTICLE; CASE CONTROL STUDY; CHINESE; CONTROLLED STUDY; FEMALE; GENE ACTIVITY; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HLA DP GENE; HOMOZYGOTE; HUMAN; INFECTION PREVENTION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK REDUCTION; SEX; SINGLE NUCLEOTIDE POLYMORPHISM; VIRAL CLEARANCE; VIRUS GENE;

ADULT; ALCOHOL DRINKING; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CHINA; FEMALE; GENOTYPE; HEPATITIS B, CHRONIC; HLA-DP ANTIGENS; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC;

HEPATITIS B VIRUS;

EID: 84861946110     PISSN: 15671348     EISSN: 15677257     Source Type: Journal    
DOI: 10.1016/j.meegid.2012.03.026     Document Type: Article

References (30)

1. Alward W.L., McMahon B.J., Hall D.B., Heyward W.L., Francis D.P., Bender T.R. The long-term serological course of asymptomatic hepatitis B virus carriers and the development of primary hepatocellular carcinoma. J. Infect. Dis. 1985, 151:604-609.
2. An P., Winkler C., Guan L., O'Brien S.J., Zeng Z. A common HLA-DPA1 variant is a major determinant of hepatitis B virus clearance in Han Chinese. J. Infect. Dis. 2011, 203:943-947.
3. Guideline on prevention and treatment of chronic hepatitis B in China (2005). Chin. Med. J. (Engl) 2007, 120:2159-2173. Chinese Society of Hepatology (C.M.A.C.S.o.I.D.), Chinese Medical Association.
4. Cochran W.G. The combination of estimates from different experiments. Biometrics 1954, 10:101-129.
5. Deng G., Zhou G., Zhai Y., Li S., Li X., Li Y., Zhang R., Yao Z., Shen Y., Qiang B., Wang Y., He F. Association of estrogen receptor alpha polymorphisms with susceptibility to chronic hepatitis B virus infection. Hepatology 2004, 40:318-326.
6. DerSimonian R., Laird N. Meta-analysis in clinical trials. Control Clin. Trials 1986, 7:177-188.
7. Diaz G., Amicosante M., Jaraquemada D., Butler R.H., Guillen M.V., Sanchez M., Nombela C., Arroyo J. Functional analysis of HLA-DP polymorphism: a crucial role for DPbeta residues 9, 11, 35, 55, 56, 69 and 84-87 in T cell allorecognition and peptide binding. Int. immunol. 2003, 15:565-576.
8. Ding K., Zhou K., He F., Shen Y. LDA-a java-based linkage disequilibrium analyzer. Bioinformatics 2003, 19:2147-2148.
9. Egger M., Davey Smith G., Schneider M., Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997, 315:629-634.
10. Fattovich G., Bortolotti F., Donato F. Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors. J. Hepatol. 2008, 48:335-352.
11. Frodsham A.J. Host genetics and the outcome of hepatitis B viral infection. Transpl. Immunol. 2005, 14:183-186.
12. Godkin A., Davenport M., Hill A.V. Molecular analysis of HLA class II associations with hepatitis B virus clearance and vaccine non responsiveness. Hepatology 2005, 41:1383-1390.
13. Guo X., Zhang Y., Li J., Ma J., Wei Z., Tan W., O'Brien S.J. Strong influence of human leukocyte antigen (HLA)-DP gene variants on development of persistent chronic hepatitis B virus carriers in the Han Chinese population. Hepatology 2011, 53:422-428.
14. Handunnetthi L., Ramagopalan S.V., Ebers G.C., Knight J.C. Regulation of major histocompatibility complex class II gene expression, genetic variation and disease. Genes Immun. 2010, 11:99-112.
15. Higgins J.P., Thompson S.G., Deeks J.J., Altman D.G. Measuring inconsistency in meta-analyses. BMJ 2003, 327:557-560.
16. Hu L., Zhai X., Liu J., Chu M., Pan S., Jiang J., Zhang Y., Wang H., Chen J., Shen H., Hu Z. Genetic variants in HLA-DP/DQ influence both hepatitis B virus clearance and hepatocellular carcinoma development 2011, Hepatology.
17. Kamatani Y., Wattanapokayakit S., Ochi H., Kawaguchi T., Takahashi A., Hosono N., Kubo M., Tsunoda T., Kamatani N., Kumada H., Puseenam A., Sura T., Daigo Y., Chayama K., Chantratita W., Nakamura Y., Matsuda K. A genome-wide association study identifies variants in the HLA-DP locus associated with chronic hepatitis B in Asians. Nat. Genet. 2009, 41:591-595.
18. Lai C.L., Ratziu V., Yuen M.F., Poynard T. Viral hepatitis B. Lancet 2003, 362:2089-2094.
19. Lau K.C., Lam C.W., Law C.Y., Lai S.T., Tsang T.Y., Siu C.W., To W.K., Leung K.F., Mak C.M., Poon W.T., Chan P.K., Chan Y.W. Non-invasive screening of HLA-DPA1 and HLA-DPB1 alleles for persistent hepatitis B virus infection: susceptibility for vertical transmission and toward a personalized approach for vaccination and treatment. Clin. Chim. Acta 2011, 412:952-957.
20. Li J., Yang D., He Y., Wang M., Wen Z., Liu L., Yao J., Matsuda K., Nakamura Y., Yu J., Jiang X., Sun S., Liu Q., Song Q., Chen M., Yang H., Tang F., Hu X., Wang J., Chang Y., He X., Chen Y., Lin J. Associations of HLA-DP variants with hepatitis B virus infection in southern and northern Han Chinese populations: a multicenter case-control study. PLoS One 2011, 6:e24221.
21. Mantel N., Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J. Natl. Cancer Inst. 1959, 22:719-748.
22. Mays N., Pope C., Popay J. Systematically reviewing qualitative and quantitative evidence to inform management and policy-making in the health field. J. Health Serv. Res. Policy 2005, 10(Suppl 1):6-20.
23. Mbarek H., Ochi H., Urabe Y., Kumar V., Kubo M., Hosono N., Takahashi A., Kamatani Y., Miki D., Abe H., Tsunoda T., Kamatani N., Chayama K., Nakamura Y., Matsuda K. A genome-wide association study of chronic hepatitis B identified novel risk locus in a Japanese population. Hum. Mol. Genet. 2011, 20:3884-3892.
24. O'Brien T.R., Kohaar I., Pfeiffer R.M., Maeder D., Yeager M., Schadt E.E., Prokunina-Olsson L. Risk alleles for chronic hepatitis B are associated with decreased mRNA expression of HLA-DPA1 and HLA-DPB1 in normal human liver. Genes Immun. 2011, 12:428-433.
25. Pieters J. MHC class II-restricted antigen processing and presentation. Adv. immunol. 2000, 75:159-208.
26. Segal S., Hill A.V. Genetic susceptibility to infectious disease. Trends Microbiol. 2003, 11:445-448.
27. Singh R., Kaul R., Kaul A., Khan K. A comparative review of HLA associations with hepatitis B and C viral infections across global populations. World J. Gastroenterol. 2007, 13:1770-1787.
28. Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur. J. Epidemiol. 2010, 25:603-605.
29. Wang L., Wu X.P., Zhang W., Zhu D.H., Wang Y., Li Y.P., Tian Y., Li R.C., Li Z., Zhu X., Li J.H., Cai J., Liu L., Miao X.P., Liu Y., Li H. Evaluation of genetic susceptibility loci for chronic hepatitis B in Chinese: two independent case-control studies. PLoS One 2011, 6:e17608.
30. Yuen M.F., Wong D.K., Sablon E., Tse E., Ng I.O., Yuan H.J., Siu C.W., Sander T.J., Bourne E.J., Hall J.G., Condreay L.D., Lai C.L. HBsAg seroclearance in chronic hepatitis B in the Chinese: virological, histological, and clinical aspects. Hepatology 2004, 39:1694-1701.